{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:06:43Z","timestamp":1767211603435},"reference-count":20,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T00:00:00Z","timestamp":1330041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2012,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Subtherapeutic international normalized ratio (INR) is frequently encountered in clinical practice, and patients with high\u2010risk atrial fibrillation (AF) and with mechanical heart valve (MHV) with inadequate anticoagulation may be exposed to an increased risk of thromboembolic events (TE). However, there are no prospective data evaluating this risk. Consecutive patients with a history of stable anticoagulation, but with a subtherapeutic INR, were prospectively included. Data on use and dose of low\u2010molecular weight heparin (LMWH) bridging therapy were collected. The incidence of objectively confirmed TE and of major bleeding events within 90 days after the index INR was assessed. Five hundred and one patients with INR value 0.5\u20131 INR units below the lower limit of the patient\u2010specific target INR were included in the study (280 with MHV and 221 with AF and CHADS2 score \u22653). LMWH was prescribed for 64 patients (12.8%). During follow\u2010up, seven patients had a TE (1.40%; 95% confidence interval 0.68, 2.86%; 5.58 events for 100 patients year). All the events occurred within 14 days after the index INR. When we consider only patients who did not receive bridging therapy, the incidence of TE was 1.14% (5 of 437 patients; 95% confidence interval 0.49, 2.64%; 4.58 events for 100 patients year). There were no major bleeding events. The risk of TE in this population was not negligible. Given the frequent observation of subtherapeutic INR levels when monitoring vitamin K antagonists, this finding warrants additional investigation to improve the management of these patients. Am. J. Hematol. 2012. \u00a9 2012 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/ajh.23119","type":"journal-article","created":{"date-parts":[[2012,1,19]],"date-time":"2012-01-19T14:22:06Z","timestamp":1326982926000},"page":"384-387","source":"Crossref","is-referenced-by-count":29,"title":["Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: A prospective multicenter cohort study"],"prefix":"10.1002","volume":"87","author":[{"given":"Francesco","family":"Dentali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Malato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Poli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo Nicola Dario","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Di Gennaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Rancan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Pastori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Grifoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Squizzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Siragusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni di","family":"Minno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Ageno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,2,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0658"},{"key":"e_1_2_5_3_2","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/CIRCULATIONAHA.106.177292","article-title":"ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation","volume":"114","author":"Fuster V","year":"2006","journal-title":"Circulation"},{"key":"e_1_2_5_4_2","doi-asserted-by":"crossref","first-page":"546S","DOI":"10.1378\/chest.08-0678","article-title":"Antithrombotic therapy in atrial fibrillation: American college of chest physicians evidence\u2010based clinical practice guidelines (8th ed)","volume":"133","author":"Singer DE","year":"2008","journal-title":"Chest"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0724"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0670"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.5.1155"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.3.239"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00198-3"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)01109-9"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.09.058"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022913"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.28.8.960"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2008.06.030"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0675"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.89.5.527"},{"key":"e_1_2_5_17_2","first-page":"285","article-title":"Periprocedural bridging therapy with low\u2010molecular\u2010weight heparin in chronically anticoagulated patients with prosthetic mechanical heart valves: Experience in 116 patients from the prospective BRAVE registry","volume":"16","author":"Hammerstingl C","year":"2007","journal-title":"J Heart Valve Dis"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.22.2864"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.109.862763"},{"key":"e_1_2_5_20_2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1160\/TH08-09-0626","article-title":"Subtherapeutic oral anticoagulant therapy: Frequency and risk factors","volume":"101","author":"Rombouts E","year":"2009","journal-title":"Thromb Hemost"},{"key":"e_1_2_5_21_2","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1055\/s-0038-1665430","article-title":"Thrombotic events during oral anticoagulant treatment: Results of the inception\u2010cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian study on complications of oral anticoagulant therapy)","volume":"78","author":"Palareti G","year":"1997","journal-title":"Thromb Hemost"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.23119","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.23119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T13:34:03Z","timestamp":1697463243000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.23119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,24]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["10.1002\/ajh.23119"],"URL":"https:\/\/doi.org\/10.1002\/ajh.23119","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,24]]}}}